Cushing Syndrome, along with Conn's Syndrome (Primary Hyperaldosteronism) and Pheochromocytoma, make up the three primary adrenal disorders. These conditions stem from tumors in the adrenal glands ...

The Food and Drug Administration (FDA) has approved Isturisa ® (osilodrostat) for the treatment of endogenous hypercortisolemia in adults with Cushing syndrome for whom surgery is not an option or has ...

The Food and Drug Administration (FDA) has approved Isturisa ® (osilodrostat) for the treatment of endogenous hypercortisolemia in adults with Cushing syndrome for whom surgery is not an option ...

primary amenorrhea Serum total testosterone 2.6 nmol/l (75 ng/dl) 4.6 nmol/l (133 ng/dl) 3.2 nmol/l (92 ng/dl) 4.5 nmol/l (130 ng/dl) Screening test confirming Cushing's syndrome Overnight LDDST ...

There are many people with online courses and cure-all products to sell you to help with stress. That said, is "cortisol ...

Nearly a quarter of patients with difficult-to-control type 2 diabetes have hypercortisolism, with even higher prevalence ...

Corcept sees 40% growth in 2025 revenue with promising trials, expanded patient base, and strong projections. Read my ...

Type 2 diabetes is a global health concern, especially in low- and middle-income countries, where its prevalence is rapidly increasing ...

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of ...

The treatment strategy for congenital adrenal hyperplasia is burdensome and had not changed in more than 70 years until the ...

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic ...

We recently published a list of 10 Best Multibagger Penny Stocks to Buy According to Billionaires. In this article, we are ...